Outcomes included measures of AD pathology and diagnosis.<h4>Results</h4>Within underrepresented populations, we replicated previously reported effects of FLT1 and FLT4, whereby higher protein abundance was observed in the AD brain and was associated with higher neuropathology burden. The gene discussed is FLT4; the disease is Alzheimer disease.